Cuu Long Pharmaceutical JSC (HOSE:DCL)
Vietnam
· Delayed Price · Currency is VND 54,400
+300 (0.55%)
At close: Mar 6, 2026
HOSE:DCL Revenue
In the year 2025, Cuu Long Pharmaceutical JSC had annual revenue of 1.32T VND with 1.13% growth. Cuu Long Pharmaceutical JSC had revenue of 372.59B in the quarter ending December 31, 2025, a decrease of -26.98%.
Revenue
1,321.59B
Revenue Growth
+1.13%
P/S Ratio
3.04
Revenue / Employee
1.50B
Employees
880
Market Cap
4,017.26B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1,321.59B | 14.79B | 1.13% |
| Dec 31, 2024 | 1,306.80B | 162.85B | 14.24% |
| Dec 31, 2023 | 1,143.95B | 128.26B | 12.63% |
| Dec 31, 2022 | 1,015.69B | 312.05B | 44.35% |
| Dec 31, 2021 | 703.63B | 32.39B | 4.83% |
| Jan 1, 2021 | Pro | Pro | Pro |
| Jan 1, 2020 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Binh Dinh Pharmaceutical and Medical Equipment JSC | 1,865.23B |
| Traphaco JSC | 2,651.81B |
| Ha Tay Pharmaceutical JSC | 2,402.04B |
| Domesco Medical Import - Export Joint-Stock | 2,078.82B |
| Imexpharm | 2,441.09B |
| OPC Pharmaceutical JSC | 1,122.99B |
| Central Pharmaceutical Joint Stock Company No3 | 438.01B |
| Pharmedic Pharmaceutical Medicinal JSC | 546.57B |